IBX 0.00% 4.0¢ imagion biosystems limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 47 Posts.
    lightbulb Created with Sketch. 289
    Hi All
    We have released the Quarterly Activity Report and Appendix 4C for the period ending on 31 December 2022.

    Highlights include:
    • Imagion presented results from MagSense® HER2 Phase I study at global breast cancer meeting showing safety and detectability
    • Tasks expert panel of radiologists with independent blinded review of the images from the Phase I study
    • Received $2.5 million R&D tax incentive

    Read the full announcement here: https://imagionbiosystems.com/news/quarterly-activity-report-quarter-ending-31-december-2022/
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.